Influence Graph

Innoviva Network Expansion Signals Coordinated Healthcare Investment Amidst Strong Buy Rating

The addition of four new co-actors, including financial firms Cantor Fitzgerald and Squarepoint Ops and pharmaceutical brands Anoro Ellipta and Trelegy Ellipta (both GlaxoSmithKline products), significantly broadens the network surrounding Innoviva Inc. This expansion, coupled with Innoviva's 'Moderate Buy' consensus rating, strongly indicates a coordinated and strategic investment drive in the healthcare and pharmaceutical sectors, likely spurred by market confidence in respiratory drug developments.

dormant

auto detected

Confidence: 95%

Created: Sep 24, 2026 04:09

Last activity: Sep 24, 2026 04:19

Sentinel

tier: low

Participants (12)

Squarepoint Ops 12 ev Zacks Research 12 ev Group On Financial 8 ev Nasdaq 8 ev Glaxosmithkline 8 ev Wealth Concepts 8 ev Trelegy Ellipta 8 ev Newedge Advisors 8 ev Cantor Fitzgerald 8 ev Anoro Ellipta 8 ev Laura Espinoza Kendall 4 ev Susquehanna Fundamental Investments 4 ev

Recent events (2)

Innoviva, Inc. (NASDAQ:INVA) Receives Consensus Rating of “Moderate Buy” from Analysts

Sep 22, 2026 TAX_DISEASE_OVERWEIGHT Tone: 2.8 Source

Cantor Fitzgerald Glaxosmithkline Nasdaq Newedge Advisors Squarepoint Ops Trelegy Ellipta +4 more
HomeTrust Bancshares, Inc. (NYSE:HTB) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Sep 22, 2026 TAX_FNCACT_ANALYSTS Tone: 1.9 Source

Squarepoint Ops Susquehanna Fundamental Investments Zacks Research Securities and Exchange Commission Hometrust Bancshare Laura Espinoza Kendall +1 more

Event Timeline

Subject

Object

Co-mention